Rheumatology Author Prof Kevin Winthrop: Tofacitinib

Prof Kevin Winthrop from OHSU. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Kevin Winthrop discusses aged based incidence of infections with tofacitinib

Discussing Rheumatology: JAK Inhibitors

Prof Iain McInnes discusses JAK inhibitors. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Perspectives in Inflammation - Professor Emery

Past President of EULAR and Carol Nachman Prize winner. In this podcast, Professor Paul Emery discusses his work in managing early RA and the growth of his unit at Leeds into a world leading centre for rheumatology research alongside Professor Michael Weinblatt.

Rheumatology Author Prof Stanley Cohen: Upadacitinib

Prof Stanley Cohen - University of Texas. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Stanley Cohen discusses safety profile of upadacitinib

Discussing Rheumatology: Upadacitinib Safety

Prof Iain McInnes discusses upadacitinib safety. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Rheumatology Author Gustavo Citera: Interstitial Lung Disease

Dr Gustavo Citera, Head of Rheumatology at the Institute of Psychophysical Rehabilitation, Buenos Aires, Argentina.

Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Gustavo Citera discusses how JAK inhibition could be associated with interstitial lung disease events.